| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0166-2236(99)01491-5 |
| P698 | PubMed publication ID | 10631784 |
| P2093 | author name string | Berrendero F | |
| Fernández-Ruiz J | |||
| Hernández ML | |||
| Ramos JA | |||
| P2860 | cites work | Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells | Q28611143 |
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 | ||
| Role of endocannabinoids in brain development | Q33720167 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| The cannabinoid receptor: biochemical, anatomical and behavioral characterization | Q36605535 | ||
| Gap junctional communication and development | Q38203064 | ||
| Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 | ||
| Pharmacology of cannabinoid receptors | Q40437020 | ||
| Search for endogenous ligands of the cannabinoid receptor | Q40643774 | ||
| New evidence for neurotransmitter influences on brain development | Q41499648 | ||
| Strategies utilized by migrating neurons of the postnatal vertebrate forebrain. | Q41733638 | ||
| Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons | Q41885455 | ||
| delta 9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons. | Q42439738 | ||
| Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons | Q42450378 | ||
| Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain | Q42451047 | ||
| Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. | Q42463589 | ||
| Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. | Q42474019 | ||
| Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period | Q42475353 | ||
| Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain | Q42528193 | ||
| Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats | Q42539758 | ||
| Developmental aspects of anandamide: ontogeny of response and prenatal exposure | Q42637119 | ||
| Perinatal exposure toΔ9-tetrahydrocannabinol (Δ9-THC) leads to changes in opioid-related behavioral patterns in rats | Q44334179 | ||
| Effect of early exposure to delta-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain | Q44335543 | ||
| Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats | Q44350124 | ||
| Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat. | Q44993199 | ||
| Cannabinoid receptors in developing rats: detection of mRNA and receptor binding | Q45086799 | ||
| Developmental expression of cannabinoid receptor mRNA. | Q45091545 | ||
| Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. | Q45096367 | ||
| Perinatal exposure to cannabinoids alters neurochemical development in rat brain | Q48161459 | ||
| Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. | Q48225866 | ||
| Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. | Q48272826 | ||
| Changes in brain catecholamine mechanisms following perinatal exposure to marihuana | Q48297014 | ||
| Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action | Q48309971 | ||
| Cannabis and endogenous cannabinoid systems. | Q48405803 | ||
| Atypical location of cannabinoid receptors in white matter areas during rat brain development | Q48679760 | ||
| Effect of maternal delta 9-tetrahydrocannabinol on developing serotonergic system | Q48857762 | ||
| Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice | Q48940741 | ||
| Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats | Q49132636 | ||
| Maternal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) alters indolamine levels and turnover in adult male and female rat brain regions. | Q50946835 | ||
| Epidemiology of substance abuse including alcohol and cigarette smoking. | Q51759221 | ||
| The Ottawa Prenatal Prospective Study (OPPS): methodological issues and findings--it's easy to throw the baby out with the bath water. | Q52055467 | ||
| The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. | Q52211667 | ||
| Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. | Q52218018 | ||
| Ontogeny of the metencephalic, mesencephalic and diencephalic content of catecholamines as measured by high performance liquid chromatography with electrochemical detection. | Q52248273 | ||
| Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny | Q52293274 | ||
| Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes | Q59068519 | ||
| Transient expression of tyrosine hydroxylase immunoreactivity in some neurons of the rat neocortex during postnatal development | Q59578572 | ||
| Perinatal or adult exposure to cannabinoids alters male reproductive functions in mice | Q72847883 | ||
| Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat | Q74184497 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoids | Q422936 |
| P304 | page(s) | 14-20 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Trends in Neurosciences | Q3538443 |
| P1476 | title | The endogenous cannabinoid system and brain development | |
| P478 | volume | 23 |
| Q50777459 | A column switching ultrahigh-performance liquid chromatography-tandem mass spectrometry method to determine anandamide and 2-arachidonoylglycerol in plasma samples. |
| Q46167833 | Alterations in the intrinsic burst activity of Purkinje neurons in offspring maternally exposed to the CB1 cannabinoid agonist WIN 55212-2. |
| Q64910138 | Altered Swimming Behaviors in Zebrafish Larvae Lacking Cannabinoid Receptor 2. |
| Q92822812 | Altered motor development following late gestational alcohol and cannabinoid exposure in rats |
| Q30471167 | Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. |
| Q48257640 | Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. |
| Q37091279 | Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits |
| Q44052454 | Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats |
| Q35118033 | Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing |
| Q43700690 | CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells |
| Q33524983 | CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signaling |
| Q46943465 | CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. |
| Q36949750 | CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies |
| Q64073287 | Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology |
| Q37905540 | Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury |
| Q34947873 | Cannabinoid receptor CB2 modulates axon guidance |
| Q43119640 | Cannabinoid receptor agonist WIN-55,212-2 protects differentiated PC12 cells from organophosphorus- induced apoptosis. |
| Q38287134 | Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways. |
| Q52087427 | Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo. |
| Q39997512 | Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis? |
| Q37734568 | Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. |
| Q35950914 | Cannabinoids and gene expression during brain development. |
| Q46806028 | Cannabinoids--can what hurts you make you stronger? Commentary on the article by Alvarez et al. on page 653. |
| Q24628837 | Cannabis and psychosis/schizophrenia: human studies |
| Q51650698 | Cannabis use at a young age is associated with psychotic experiences. |
| Q37538579 | Cannabis use in pregnancy and early life and its consequences: animal models |
| Q35936887 | Cannabis-associated psychosis: current status of research |
| Q34133972 | Ceramide: a new second messenger of cannabinoid action |
| Q34515581 | Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis |
| Q44189376 | Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine |
| Q44493267 | Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Delta(9)-tetrahydrocannabinol |
| Q35609139 | Comparison of Cannabinoid CB(1) Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [F]MK-9470. |
| Q30465324 | Decreased parvalbumin immunoreactivity in the cortex and striatum of mice lacking the CB1 receptor |
| Q91265652 | Deletion of the cannabinoid CB1 receptor impacts on the ultrastructure of the cerebellar parallel fiber-Purkinje cell synapses |
| Q44443061 | Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors |
| Q30494037 | Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex |
| Q24613945 | Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents |
| Q37553166 | Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. |
| Q34519223 | Developmental increase in hippocampal endocannabinoid mobilization: role of metabotropic glutamate receptor subtype 5 and phospholipase C. |
| Q30505485 | Developmental regulation of CB1-mediated spike-time dependent depression at immature mossy fiber-CA3 synapses |
| Q30366747 | Developmental regulation of fear learning and anxiety behavior by endocannabinoids. |
| Q44373734 | Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex. |
| Q37349953 | Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects |
| Q92064800 | Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping |
| Q46179690 | Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. |
| Q28390570 | Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats |
| Q90149816 | Effects of cannabinoids on the development of chick embryos in ovo |
| Q44535581 | Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior |
| Q46615422 | Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. |
| Q92097847 | Endocannabinoid System and Alcohol Abuse Disorders |
| Q41807144 | Endocannabinoid System and TRPV1 Receptors in the Dorsal Hippocampus of the Rats Modulate Anxiety-like Behaviors |
| Q39031134 | Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review |
| Q30391852 | Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration |
| Q34641465 | Endocannabinoids and cannabinoid receptor genetics |
| Q34351200 | Endocannabinoids and exercise |
| Q35546025 | Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage |
| Q35164060 | Exposure to cannabinoids in the development of endogenous cannabinoid system. |
| Q26777055 | Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling |
| Q32035079 | Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture |
| Q35950888 | Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability |
| Q26865311 | Gone to Pot - A Review of the Association between Cannabis and Psychosis |
| Q37185873 | Illicit substance use in pregnancy - a review |
| Q34668606 | Impact of Cannabis Use on the Development of Psychotic Disorders |
| Q35655078 | Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. |
| Q28388698 | Low level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibition |
| Q44303656 | Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor |
| Q48462251 | Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity |
| Q37143586 | Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development |
| Q44451116 | Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia |
| Q34990029 | Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome |
| Q37029175 | Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus |
| Q30658975 | Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. |
| Q33772042 | Neuroprotective therapies after perinatal hypoxic-ischemic brain injury |
| Q36374839 | New horizons for newborn brain protection: enhancing endogenous neuroprotection |
| Q44806587 | News about therapeutic use of Cannabis and endocannabinoid system |
| Q44444709 | Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. |
| Q26823747 | Ontogenetic modifications of neuronal excitability during brain maturation: developmental changes of neurotransmitter receptors |
| Q36645783 | Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons |
| Q36007944 | Parenteral Pethidine for labour pain relief and substance use disorder: 20-year follow-up cohort study in offspring |
| Q36813329 | Perinatal delta-9-tetrahydrocannabinol exposure disrupts social and open field behavior in adult male rats |
| Q44535579 | Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats |
| Q46513876 | Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity |
| Q92097819 | Physiology of the Endocannabinoid System During Development |
| Q35745621 | Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex. |
| Q35815626 | Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol lipase does not cause neurodegeneration in neonatal mice. |
| Q28373821 | Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences |
| Q42598594 | Prenatal elevation of endocannabinoids corrects the unbalance between dopamine systems and reduces activity in the Naples High Excitability rats. |
| Q92347517 | Prenatal exposure to tobacco and marijuana and child autonomic regulation and reactivity: An analysis of indirect pathways via maternal psychopathology and parenting |
| Q37164815 | Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure |
| Q40387198 | Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain |
| Q33814760 | Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses |
| Q44506503 | Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats |
| Q48446296 | Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats |
| Q34268010 | Requirement of cannabinoid CB1 receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections |
| Q38682524 | Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model |
| Q38261934 | Septo-hippocampo-septal loop and memory formation |
| Q30497561 | Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior |
| Q37522043 | Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. |
| Q33635642 | Stress and adolescent hippocampal neurogenesis: diet and exercise as cognitive modulators |
| Q37070250 | Tentative evidence for striatal hyperactivity in adolescent cannabis-using boys: a cross-sectional multicenter fMRI study |
| Q39420404 | The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development |
| Q44141102 | The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. |
| Q34305854 | The endocannabinoid nervous system: unique opportunities for therapeutic intervention |
| Q35876026 | The endocannabinoid system and its therapeutic exploitation |
| Q36778571 | The endocannabinoid system and neurogenesis in health and disease. |
| Q37083923 | The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) |
| Q37568621 | The endocannabinoid system during development: emphasis on perinatal events and delayed effects. |
| Q31031589 | The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. |
| Q35204851 | The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis |
| Q35954057 | The endocannabinoid system: physiology and pharmacology. |
| Q34786832 | The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. |
| Q35186496 | Transgenic and knock-out mouse pups: the growing need for behavioral analysis. |
| Q38248001 | Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury |
| Q37272835 | Wiring and firing neuronal networks: endocannabinoids take center stage |
| Q51993486 | [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders]. |
Search more.